Valeant Pharmaceuticals Buys Russia's Natur Produkt
Montréal, Québec-based Valeant Pharmaceuticals International Inc., which develops, manufactures and markets pharmaceutical products, primarily in the areas of dermatology, neurology and branded generics, closed its acquisition of Natur Produkt International JSC, a specialty pharmaceutical company located in Saint Petersburg, Russia. The purchase price was approximately C$163 million. Natur Produkt has in past received investment from Russian private equity firms Renova Capital and Quadriga Capital Russia.
5 February 2013•1 min read
